Education
About Us
Working with TipRanks
Follow Us
Amedisys Inc (AMED)
NASDAQ:AMED
AMED Stock Chart & Stats
Day’s Range― - ―
52-Week Range$82.15 - $98.95
Previous CloseN/A
Volume84.60K
Average Volume (3M)297.21K
Market Cap
$2.96B
Enterprise Value$3.47B
Total Cash (Recent Filing)$20.23M
Total Debt (Recent Filing)$7.39M
Price to Earnings (P/E)36.0
Beta0.41
Next Earnings
Apr 23, 2025EPS Estimate
1.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.51
Shares Outstanding32,754,463
10 Day Avg. Volume304,406
30 Day Avg. Volume297,213
Standard Deviation0.11
R-Squared0.13
Alpha-0.01
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)N/A
Price to Sales (P/S)1.28
Price to Cash Flow (P/CF)7.00
P/FCF Ratio7.10
Enterprise Value/Market Cap1.17
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.50
Enterprise Value/Ebitda17.52
Forecast
1Y Price Target
$100.75Price Target Upside9.51% Upside
Rating ConsensusHold
Number of Analyst Covering6
---
Amedisys News
PremiumCompany Announcements
Amedisys Reports 2024 Financial Results Amid Merger Plans
PremiumCompany Announcements
Amedisys Reports Q4 2024 Financial Results Amid Merger Plans
---
Bulls Say, Bears Say
Bulls Say
Merger And AcquisitionCertain closing conditions relating to government approvals are no longer conditions to the consummation of the merger, indicating a smoother path to completion.
Revenue PerformanceHome health revenue of $377.0 million beat our $373.3 million estimate as average revenue per episode of $3,030 exceeded our $2,997 estimate and same-store non-Medicare revenue increased 19%.
Bears Say
Financial PerformanceThe 4Q24 results came in below both consensus estimates and the analyst's model.
---
Ownership Overview
2.19% Insiders
24.02% Mutual Funds
37.62% Other Institutional Investors
9.98% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AMED FAQ
What was Amedisys Inc’s price range in the past 12 months?
Amedisys Inc lowest stock price was $82.15 and its highest was $98.95 in the past 12 months.
What is Amedisys Inc’s market cap?
Amedisys Inc’s market cap is $2.96B.
When is Amedisys Inc’s upcoming earnings report date?
Amedisys Inc’s upcoming earnings report date is Apr 23, 2025 which is in 51 days.
How were Amedisys Inc’s earnings last quarter?
Amedisys Inc released its earnings results on Feb 26, 2025. The company reported $0.96 earnings per share for the quarter, missing the consensus estimate of $1.048 by -$0.088.
Is Amedisys Inc overvalued?
According to Wall Street analysts Amedisys Inc’s price is currently Undervalued.
Does Amedisys Inc pay dividends?
Amedisys Inc does not currently pay dividends.
What is Amedisys Inc’s EPS estimate?
Amedisys Inc’s EPS estimate is 1.04.
How many shares outstanding does Amedisys Inc have?
Amedisys Inc has 32,754,463 shares outstanding.
What happened to Amedisys Inc’s price movement after its last earnings report?
Amedisys Inc reported an EPS of $0.96 in its last earnings report, missing expectations of $1.048. Following the earnings report the stock price went up 0.12%.
Which hedge fund is a major shareholder of Amedisys Inc?
Currently, no hedge funds are holding shares in AMED
---
Amedisys Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$100.75 (9.51% Upside)
$100.75 (9.51% Upside)
Blogger Sentiment
Neutral
AMED Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 153.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.64%
12-Months-Change
Fundamentals
Return on Equity
3.93%
Trailing 12-Months
Asset Growth
3.81%
Trailing 12-Months
Company Description
Amedisys Inc
Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.
---
AMED Stock 12 Month Forecast
Average Price Target
$100.75
▲(9.51% Upside)
Technical Analysis
AMN Healthcare Services
―
Chemed
―
Healthcare Services
―
Encompass Health
―
The Ensign Group
―
Best Analysts Covering AMED
1 Year
Unknown AnalystRBC Capital
Not Ranked
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
reiterated a buy rating 2 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
---